Details for Patent: 12,678,405
✉ Email this page to a colleague
Which drugs does patent 12,678,405 protect, and when does it expire?
Patent 12,678,405 protects VYSCOXA and is included in one NDA.
Drugs Protected by US Patent 12,678,405
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Carwin Pharm Assoc | VYSCOXA | celecoxib | SUSPENSION;ORAL | 211759-001 | Jul 29, 2025 | RX | Yes | Yes | 12,678,405 | ⤷ Start Trial | Y | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
